apparently, Monday and Tuesday, Mel/Syd. a number of funds and brokers updated, per PPT announcement Monday Wilson and Patterson brokers both briefed Canaccord did the rounds with ISX team to a number of funds in Melbourne and Sydney Not a CR.
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status